Literature DB >> 16449405

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression.

Michael J Forlenza1, Gregory E Miller.   

Abstract

OBJECTIVE: We sought to understand the pathophysiological effects of depression by examining group differences in serum levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative damage.
METHODS: Our sample consisted of 169 participants. Eight-four of these participants met diagnostic criteria for clinical depression. The 85 participants in our comparison group were matched on age, gender, and ethnicity to the depressed group. 8-OHdG was measured by enzyme-linked immunosorbent assay.
RESULTS: After adjusting for age, gender, race/ethnicity, years of education, daily smoking, average number of alcoholic drinks per week, average amount of physical activity per week, and body mass index, participants in the depressed group had significantly higher levels of oxidative DNA damage compared with participants in the control group. Pairwise comparisons showed that participants with major depression had significantly higher levels of 8-OHdG than control subjects and marginally higher levels of 8-OHdG compared with those with minor depression. Furthermore, participants with recurrent episodes of depression had more oxidative damage than participants with single episodes, who in turn had more damage than healthy control subjects. Finally, participants with recurrent episodes of major depression had more DNA damage than other depressed participants, who in turn had more damage than healthy control subjects.
CONCLUSIONS: Our findings suggest that increased oxidative damage may represent a common pathophysiological mechanism, whereby depressed individuals become vulnerable to comorbid medical illness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449405     DOI: 10.1097/01.psy.0000195780.37277.2a

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  93 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.

Authors:  Andreas Johannes Schmidt; Hans-Willi Clement; Stefan Gebhardt; Ulrich Michael Hemmeter; Eberhard Schulz; Jürgen-Christian Krieg; Tilo Kircher; Philip Heiser
Journal:  J Neural Transm (Vienna)       Date:  2010-05-14       Impact factor: 3.575

Review 3.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 4.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

5.  Depression and oxidative stress: results from a meta-analysis of observational studies.

Authors:  Priya Palta; Laura J Samuel; Edgar R Miller; Sarah L Szanton
Journal:  Psychosom Med       Date:  2013-12-12       Impact factor: 4.312

6.  Oxidative stress is associated with greater mortality in older women living in the community.

Authors:  Richard D Semba; Luigi Ferrucci; Kai Sun; Jeremy Walston; Ravi Varadhan; Jack M Guralnik; Linda P Fried
Journal:  J Am Geriatr Soc       Date:  2007-09       Impact factor: 5.562

7.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09

8.  Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity.

Authors:  Kirstin Aschbacher; Aoife O'Donovan; Owen M Wolkowitz; Firdaus S Dhabhar; Yali Su; Elissa Epel
Journal:  Psychoneuroendocrinology       Date:  2013-03-13       Impact factor: 4.905

9.  Stress and Psychiatric Disorders: The Role of Mitochondria.

Authors:  Teresa E Daniels; Elizabeth M Olsen; Audrey R Tyrka
Journal:  Annu Rev Clin Psychol       Date:  2020-02-24       Impact factor: 18.561

10.  Lipopolysaccharide-Induced Behavioral Alterations Are Alleviated by Sodium Phenylbutyrate via Attenuation of Oxidative Stress and Neuroinflammatory Cascade.

Authors:  Ashok Jangra; Chandra Shaker Sriram; Mangala Lahkar
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.